ICON director John Climax sells 5,005 shares
ICON PLC director Dr. John Climax exercised options into 5,005 shares and sold the same number on September 16, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ICON PLC (ICLR) director Dr. John Climax reported an option exercise and same‑day share sale. On September 16, 2026 he exercised fully vested stock options to acquire 5,005 Ordinary Shares at an exercise price of $125.74 per share, then sold 5,005 Ordinary Shares at $175.00 per share. The exercised option grant, originally dated May 18, 2018, is now fully exhausted, and no remaining derivative position from this grant is reported. No Rule 10b5‑1 trading plan is indicated.
Insider Trade Summary
Exercise and Sale: 5,005 shares ($247K approx. pre-tax spread)
Exercise and Sale
3 txns
Insider
CLIMAX JOHN DR
Role
Director
Sold
5,005 shs ($876K)
Approx. gross sale proceeds
$876K
Approx. exercise cost
$629K
Approx. pre-tax spread
$247K
Share of Position Sold
70.6%
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Options F1, F2 | 5,005 | $0.00 | $0.00 |
| Exercise | Ordinary Shares | 5,005 | $125.74 | $629K |
| Sale | Ordinary Shares | 5,005 | $175.00 | $876K |
Holdings After Transaction:
Stock Options — 0 contracts (Direct);
Ordinary Shares — 2,087 shares (Direct)
Holdings Before and After:
Stock Options, 5,005 to 0 contracts (Direct);
Ordinary Shares, 2,087 to 2,087 shares (Direct)
Other Insiders: 2 other insiders reported open-market sales of this stock in the 30 days up to this filing.
Footnotes (2)
- F1. Fully vested.
- F2. The stock options expire on the eighth anniversary of the grant date, May 18, 2018, subject to automatic extension until the 30th trading day following any period during which exercise is prohibited under the Issuer's Share Trading Policy or applicable law, but in no event later than the tenth anniversary of the grant date.
Key Figures
Stock options exercised: 5,005 options
Underlying shares acquired on exercise: 5,005 Ordinary Shares
Exercise price: $125.74 per share
+4 more
7 metrics
Stock options exercised
5,005 options
Options on ICON PLC Ordinary Shares exercised on September 16, 2026
Underlying shares acquired on exercise
5,005 Ordinary Shares
Shares received from option exercise on September 16, 2026
Exercise price
$125.74 per share
Exercise price for 5,005 stock options
Shares sold
5,005 Ordinary Shares
Sale of shares on September 16, 2026
Sale price
$175.00 per share
Price for sale of 5,005 Ordinary Shares
Net shares bought/(sold)
-5,005 shares
Net of all buy/sell transactions reported in this Form 4
Options remaining from this grant
0 options
Total derivative shares following exercise of the May 18, 2018 grant
Key Terms
foreign private issuer, Rule 3a12-3(b), Sections 16(b) and 16(c), Share Trading Policy
4 terms
foreign private issuer regulatory
"Due to the issuer's status as a foreign private issuer pursuant to Rule 3a12-3(b)"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
Rule 3a12-3(b) regulatory
"status as a foreign private issuer pursuant to Rule 3a12-3(b) under the Exchange Act"
Sections 16(b) and 16(c) regulatory
"transactions in the issuer's equity securities are exempt from Sections 16(b) and 16(c)"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did ICON PLC (ICLR) disclose for Dr. John Climax?
Dr. John Climax exercised stock options into 5,005 Ordinary Shares at an exercise price of $125.74 per share and sold 5,005 Ordinary Shares at $175.00 per share on September 16, 2026.
Did the September 16, 2026 ICLR transactions occur under a Rule 10b5-1 plan?
No. The filing’s Rule 10b5‑1 checkbox is not marked, and no footnote states that Dr. John Climax’s September 16, 2026 transactions were made under a Rule 10b5‑1 trading plan.
How many ICON PLC (ICLR) options did Dr. John Climax exercise and at what price?
He exercised 5,005 stock options for ICON PLC Ordinary Shares at an exercise price of $125.74 per share. The options were fully vested at the time of exercise.
What happened to Dr. John Climax’s exercised ICON PLC option grant after these transactions?
The filing reports 0 derivative shares remaining after exercising 5,005 stock options, indicating that this particular May 18, 2018 option grant is fully exhausted.
Why are Dr. John Climax’s ICON PLC (ICLR) transactions exempt from Section 16(b) and 16(c)?
The remarks state that ICON PLC qualifies as a foreign private issuer under Rule 3a12‑3(b). As a result, Dr. John Climax’s transactions in ICON PLC equity securities are exempt from Sections 16(b) and 16(c) of the Exchange Act.
AI-generated analysis. How Rhea-AI works. Not financial advice.
